Toxoplasma gondii, PCR
Use
This test is intended to be used in conjunction with standard serological tests to aid in the diagnosis of infections caused by Toxoplasma gondii.
Special Instructions
The test is developed and its performance characteristics are determined by LabCorp Laboratories. It has not been cleared or approved by the U.S. FDA as the FDA has determined that such clearance or approval is not necessary. The test is used for clinical purposes and should not be regarded as investigational or research.
Limitations
The test should be used in conjunction with other serological tests for Toxoplasma gondii to confirm infection. It is important to note that the absence of Toxoplasma gondii DNA does not conclusively rule out infection as the parasite may be present at levels below the detection limit of the assay. Additional confirmatory or reflex tests may be required.
Methodology
PCR-based (Real-time polymerase chain reaction (PCR))
Biomarkers
LOINC Codes
- 29904-0
- 29904-0
Result Turnaround Time
4-5 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
Sterile container
Storage Instructions
CSF is stable at room temperature or refrigerated for seven days or frozen for 90 days.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 90 days |
